Optimal Timing of Computerized Cognitive Training for Older Intensive Care Unit Survivors
NCT ID: NCT05467410
Last Updated: 2026-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
40 participants
INTERVENTIONAL
2023-11-15
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
NCT06411561
A Problem Solving Intervention for Post-ICU Cognitive Impairment in Older Adults
NCT03972384
Simultaneous Recumbent Cycling and Cognitive Training
NCT04556227
Cognitive Exercises in Survivors of a Prolonged ICU Stay.
NCT05111275
Improving the Recovery and Outcome Every Day After the ICU
NCT03095417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COG-AM
30-minute morning session of a laptop-based computerized cognitive training intervention, delivered between the hours of 09:00 AM - 12:00 PM, in addition to UC
COG-AM
Participants who are randomized to the COG-AM intervention group will be asked to complete 30-minute computerized cognitive training (Lumosity cognitive training program) sessions during morning hours (between 09:00-12:00), for a total of 7 days or until hospital discharge, whichever comes first. Participants will complete cognitive training sessions in each of the following subdomains: memory, attention, problem solving, cognitive flexibility, and processing speed.
COG-PM
30-minute afternoon/evening session of a laptop-based computerized cognitive training intervention, delivered between the hours of 15:00 PM - 18:00 PM, in addition to UC
COG-PM
Participants who are randomized to the COG-PM intervention group will be asked to complete 30-minute computerized cognitive training (Lumosity cognitive training program) sessions during late afternoon/early evening hours (between 15:00-18:00), for a total of 7 days or until hospital discharge, whichever comes first. Participants will complete cognitive training sessions in each of the following subdomains: memory, attention, problem solving, cognitive flexibility, and processing speed.
UC
Standard post-ICU inpatient care/usual care, which includes physical/occupational therapy as ordered by treatment team
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COG-AM
Participants who are randomized to the COG-AM intervention group will be asked to complete 30-minute computerized cognitive training (Lumosity cognitive training program) sessions during morning hours (between 09:00-12:00), for a total of 7 days or until hospital discharge, whichever comes first. Participants will complete cognitive training sessions in each of the following subdomains: memory, attention, problem solving, cognitive flexibility, and processing speed.
COG-PM
Participants who are randomized to the COG-PM intervention group will be asked to complete 30-minute computerized cognitive training (Lumosity cognitive training program) sessions during late afternoon/early evening hours (between 15:00-18:00), for a total of 7 days or until hospital discharge, whichever comes first. Participants will complete cognitive training sessions in each of the following subdomains: memory, attention, problem solving, cognitive flexibility, and processing speed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ICU length of stay ≥ 24 hours
* Active transfer order or expected discharge from ICU to a post-ICU unit
* Fluent in English
* Functional independence prior to hospital admission (Katz Index = 6)
* No suspicion of Alzheimer's disease/dementia
* Current hospitalization at University of Washington Medical Center or Harborview Medical Center
Exclusion Criteria
* Documented history of bipolar disorder or schizophrenia
* Documented acute stroke or acute traumatic brain injury
* Severe visual impairment
* Severe hearing impairment
* Severe dominant arm paresis/paralysis
* Transfer from inpatient rehabilitation or skilled nursing care facility
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Association of Critical Care Nurses
OTHER
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maya Elias, PhD, RN
Assistant Professor, Department of Biobehavioral Nursing and Health Informatics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maya N Elias, PhD, MA, RN
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harborview Medical Center
Seattle, Washington, United States
University of Washington Medical Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40067
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
STUDY00014922
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.